Yes seriously.
Solid tumours are supremely difficult to treat.
CF33 is not just about the efficacy which is universal BTW
it's also about the lack of adverse events, cost of Tx, ease of use, adaptability for other medications on the list you so kindly provided.
CF33 can be the goat.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.003(22.7%) |
Mkt cap ! $85.87M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.1¢ | $262.0K | 21.60M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1508773 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 10947552 | 42 |
View Market Depth
| Last trade - 11.26am 27/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |